Qiagen NV | QIA - Pre Tax Profit

Stock Price
42.05
Daily Change
0.66 1.58%
Monthly
-5.97%
Yearly
14.16%
Q1 Forecast
40.37

Qiagen NV reported $134.73M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
argenx SE USD 386.05M 99.15M Sep/2025
Avita Medical AUD -23.77M 12.2M Jun/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Moderna USD -187M 631M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Tectonic Therapeutic USD -19.04M 25K Sep/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025